1
|
van de Borne P, Peeters A, Janssens L, Leone A, Lemmens R, Verhaegen A, De Meulemeester M, Balthazar Y, Heijmans S, Calozet Y, Paquot N, Carlier S, Hemelsoet D, Bray S, Ray KK. Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study. Acta Cardiol 2024; 79:20-29. [PMID: 35442151 DOI: 10.1080/00015385.2022.2030568] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Revised: 10/01/2021] [Accepted: 01/11/2022] [Indexed: 01/21/2023]
Abstract
BACKGROUND Cardiovascular disease (CVD) is one of the leading causes of death in Belgium. Current strategies for the prevention and management of CVD focus on reducing low-density lipoprotein cholesterol (LDL-C) levels. This analysis assessed whether LDL-C goals, recommended by the European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines, were being achieved in a Belgian study population. METHODS The cross-sectional, observational, DA VINCI study enrolled patients prescribed lipid-lowering therapy (LLT) between 21 June 2017 and 20 November 2018. Data for patients from Belgium were extracted for this country-specific analysis. Primary endpoint was the proportion of patients who achieved 2016 ESC/EAS risk-based LDL-C goals; attainment of 2019 risk-based LDL-C goals was evaluated post hoc. RESULTS Of 497 enrolled patients, 41% were female and mean age was 68 years. Among subjects with an LDL-C measurement on stabilised LLT, moderate-intensity statin monotherapy was the most prescribed LLT regimen (59%). Overall, 63% of patients achieved their risk-based LDL-C goals according to the 2016 ESC/EAS guidelines. Among patients with established ASCVD, risk-based LDL-C goal attainment was higher in patients with peripheral arterial disease (53%) than patients with coronary (37%) and cerebrovascular disease (42%). According to the updated 2019 ESC/EAS guidelines, less than half (41%) of patients achieved their risk-based LDL-C goal. The proportion of primary and secondary prevention patients who achieved 2019 risk-based LDL-C goals was 59% and 18%, respectively. CONCLUSION These findings reveal a large gap between the LDL-C goals advocated by the ESC/EAS and the levels achieved in routine clinical practice in Belgium.
Collapse
Affiliation(s)
- Philippe van de Borne
- Department of Cardiology, Erasme Hospital, University Libre of Brussels, Brussels, Belgium
| | - André Peeters
- Department of Neurology, Saint Luc University Clinic, Brussels, Belgium
| | - Luc Janssens
- Department of Cardiology, Imelda Hospital, Bonheiden, Belgium
| | - Attilio Leone
- Department of Cardiology, Tivoli University Hospital Centre, La Louvière, Belgium
| | - Robin Lemmens
- Department of Neurology, University Hospitals Leuven and KU Leuven, Leuven, Belgium
| | - Ann Verhaegen
- Department of Endocrinology, Diabetes and Metabolism, Antwerp University Hospital, Edegem, Belgium
| | | | | | | | | | - Nicolas Paquot
- Department of Diabetology, Nutrition and Metabolic Diseases, Sart Tilman University Hospital Center, Liège, Belgium
| | - Stéphane Carlier
- Department of Cardiology, Ambroise Paré Hospital and University of Mons (UMONS), Mons, Belgium
| | | | - Sarah Bray
- Global Biostatistical Science, Amgen Ltd, Cambridge, UK
| | - Kausik K Ray
- Imperial Centre for Cardiovascular Disease Prevention and Imperial Clinical Trials Unit, Imperial College London, London, UK
| |
Collapse
|
2
|
Danhieux K, Buffel V, Remmen R, Wouters E, van Olmen J. Scale-up of a chronic care model-based programme for type 2 diabetes in Belgium: a mixed-methods study. BMC Health Serv Res 2023; 23:141. [PMID: 36759890 PMCID: PMC9911183 DOI: 10.1186/s12913-023-09115-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Accepted: 01/27/2023] [Indexed: 02/11/2023] Open
Abstract
BACKGROUND Type 2 diabetes (T2D) is an increasingly dominant disease. Interventions are more effective when carried out by a prepared and proactive team within an organised system - the integrated care (IC) model. The Chronic Care Model (CCM) provides guidance for its implementation, but scale-up of IC is challenging, and this hampers outcomes for T2D care. In this paper, we used the CCM to investigate the current implementation of IC in primary care in Flanders (Belgium) and its variability in different practice types. METHODS Belgium contains three different primary-care practice types: monodisciplinary fee-for-service practices, multidisciplinary fee-for-service practices and multidisciplinary capitation-based practices. Disproportional sampling was used to select a maximum of 10 practices for each type in three Flemish regions, leading to a total of 66 practices. The study employed a mixed methods design whereby the Assessment of Chronic Illness Care (ACIC) was complemented with interviews with general practitioners, nurses and dieticians linked to the 66 practices. RESULTS The ACIC scores of the fee-for-service practices - containing 97% of Belgian patients - only corresponded to basic support for chronic illness care for T2D. Multidisciplinary and capitation-based practices scored considerably higher than traditional monodisciplinary fee-for-service practices. The region had no significant impact on the ACIC scores. Having a nurse, being a capitation practice and having a secretary had a significant effect in the regression analysis, which explained 75% of the variance in ACIC scores. Better-performing practices were successful due to clear role-defining, task delegation to the nurse, coordination, structured use of the electronic medical record, planning of consultations and integration of self-management support, and behaviour-change intervention (internally or using community initiatives). The longer nurses work in primary care practices, the higher the chance that they perform more advanced tasks. CONCLUSIONS Besides the presence of a nurse or secretary, also working multidisciplinary under one roof and a capitation-based financing system are important features of a system wherein IC for T2D can be scaled-up successfully. Belgian policymakers should rethink the role of paramedics in primary care and make the financing system more integrated. As the scale-up of the IC varied highly in different contexts, uniform roll-out across a health system containing multiple types of practices may not be successful.
Collapse
Affiliation(s)
- Katrien Danhieux
- Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium. .,Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
| | - Veerle Buffel
- grid.5284.b0000 0001 0790 3681Center for Population, Family and Health, University of Antwerp, Antwerp, Belgium
| | - Roy Remmen
- grid.5284.b0000 0001 0790 3681Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium
| | - Edwin Wouters
- grid.5284.b0000 0001 0790 3681Center for Population, Family and Health, University of Antwerp, Antwerp, Belgium
| | - Josefien van Olmen
- grid.5284.b0000 0001 0790 3681Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium ,grid.11505.300000 0001 2153 5088Institute of Tropical Medicine Antwerp, Antwerp, Belgium
| |
Collapse
|
3
|
Veerle B, Katrien D, Bos P, Roy R, Josefien VO, Edwin W. Development and operationalization of a data framework to assess quality of integrated diabetes care in the fragmented data landscape of Belgium. BMC Health Serv Res 2022; 22:1257. [PMID: 36253775 PMCID: PMC9578257 DOI: 10.1186/s12913-022-08625-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Accepted: 09/30/2022] [Indexed: 11/25/2022] Open
Abstract
Background To assess the quality of integrated diabetes care, we should be able to follow the patient throughout the care path, monitor his/her care process and link them to his/her health outcomes, while simultaneously link this information to the primary care system and its performance on the structure and organization related quality indicators. However the development process of such a data framework is challenging, even in period of increasing and improving health data storage and management. This study aims to develop an integrated multi-level data framework for quality of diabetes care and to operationalize this framework in the fragmented Belgium health care and data landscape. Methods Based on document reviews, iterative working group discussions and expert consultations, theoretical approaches and quality indicators were identified and assessed. After mapping and assessing the validity of existing health information systems and available data sources through expert consultations, the theoretical framework was translated in a data framework with measurable quality indicators. The construction of the data base included sampling procedures, data-collection, and several technical and privacy-related aspects of linking and accessing Belgian datasets. Results To address three dimensions of quality of care, we integrated the chronic care model and cascade of care approach, addressing respectively the structure related quality indicators and the process and outcome related indicators. The corresponding data framework is based on self-collected data at the primary care practice level (using the Assessment of quality of integrated care tool), and linked health insurance data with lab data at the patient level. Conclusion In this study, we have described the transition of a theoretical quality of care framework to a unique multilevel database, which allows assessing the quality of diabetes care, by considering the complete care continuum (process and outcomes) as well as organizational characteristics of primary care practices. Supplementary Information The online version contains supplementary material available at 10.1186/s12913-022-08625-8.
Collapse
Affiliation(s)
- Buffel Veerle
- Department of Sociology, University of Antwerp, Antwerp, Belgium.
| | - Danhieux Katrien
- Department of family medicine and population health, University of Antwerp, Antwerp, Belgium
| | - Philippe Bos
- Department of Sociology, University of Antwerp, Antwerp, Belgium
| | - Remmen Roy
- Department of family medicine and population health, University of Antwerp, Antwerp, Belgium
| | - Van Olmen Josefien
- Department of family medicine and population health, University of Antwerp, Antwerp, Belgium
| | - Wouters Edwin
- Department of Sociology, University of Antwerp, Antwerp, Belgium
| |
Collapse
|
4
|
Ghattas J, Gorasso V, De Pauw R, Thunus S, Speybroeck N, Devleesschauwer B. The state of health in Belgium, 1990-2019: a benchmarking analysis based on the Global Burden of Disease 2019 study. Arch Public Health 2022; 80:222. [PMID: 36258249 PMCID: PMC9580164 DOI: 10.1186/s13690-022-00976-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Accepted: 09/30/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND In a context of decreasing resources and growing health needs, evidence-based health and care policies are essential. This study aims to assess the health trends in Belgium between 1990 and 2019, to compare the Belgian health status to that of the EU-15 countries, and to identify the main drivers in trends over time and country differences within the EU-15. METHODS We extracted estimates from the GBD 2019 study via the GBD results tool and visualization tools. We compared the Belgian health status with 14 European Union comparator countries between 1990 and 2019, and decomposed the time trends and country differences into the unique contributions of the different underlying causes of death and disability. RESULTS Life expectancy (LE) in Belgium improved significantly between 1990 and 2019 for both men and women. Belgium age-standardised mortality rates dropped significantly for men (-40%) and women (-33%) between 1990 and 2019. Overall, Belgium age-standardised disability-adjusted life year (DALY) rates dropped by 23%. This decrease is mainly due to decreasing trends in age-standardised years of life lost (YLL) rates while age-standardised years lived with disability (YLD) rates remained stable. Compared to EU-15, Belgium's ranking in terms of age-standardised DALY rates worsened for both men and women in 2019. Self-harm and falls are major causes of disease burden, with DALY rates that are higher than in many other EU-15 countries, indicating a realistic potential for improvement. Lung cancer DALY rates remain worrisome for men, and even show an increasing trend for women. Increasing trends of headache disorders, drug use disorders, and diabetes, require further attention. CONCLUSION Non-communicable diseases remain the main contributors for health burden in Belgium, with disability accounting for an increasingly larger share of the disease burden. Despite considerable improvements, Belgium's ranking for DALYs decreased between 1990 and 2019 compared to the EU-15. This study identified priority causes of disease burden based on their contributions to current evolutions and EU-15 differences. Since many of these causes are considered to be avoidable, primary and secondary prevention are crucial elements for reducing the burden of disease on the healthcare system.
Collapse
Affiliation(s)
- Jinane Ghattas
- grid.7942.80000 0001 2294 713XInstitute of Health and Society (IRSS), Université Catholique de Louvain, Brussels, Belgium
| | - Vanessa Gorasso
- Lifestyle and Chronic Diseases, Department of Epidemiology and Public Health, Rue Juliette Wytsmanstraat 14, 1050 Sciensano Brussels, Belgium ,grid.5342.00000 0001 2069 7798Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
| | - Robby De Pauw
- Lifestyle and Chronic Diseases, Department of Epidemiology and Public Health, Rue Juliette Wytsmanstraat 14, 1050 Sciensano Brussels, Belgium ,grid.5342.00000 0001 2069 7798Department of Rehabilitation Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
| | - Sophie Thunus
- grid.7942.80000 0001 2294 713XInstitute of Health and Society (IRSS), Université Catholique de Louvain, Brussels, Belgium
| | - Niko Speybroeck
- grid.7942.80000 0001 2294 713XInstitute of Health and Society (IRSS), Université Catholique de Louvain, Brussels, Belgium
| | - Brecht Devleesschauwer
- Lifestyle and Chronic Diseases, Department of Epidemiology and Public Health, Rue Juliette Wytsmanstraat 14, 1050 Sciensano Brussels, Belgium ,grid.5342.00000 0001 2069 7798Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium
| |
Collapse
|
5
|
Hosseinzadeh S, Khatirnamani Z, Bakhshi E, Heidari A, Naghipour A. Assessing related factors to fasting blood sugar and glycosylated hemoglobin in patients with type 2 diabetes simultaneously by a multivariate longitudinal marginal model. Sci Rep 2022; 12:14819. [PMID: 36050425 PMCID: PMC9436939 DOI: 10.1038/s41598-022-19241-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2021] [Accepted: 08/26/2022] [Indexed: 12/01/2022] Open
Abstract
The multivariate marginal model can be used to simultaneously examine the factors affecting both FBS and HbA1c using longitudinal data. The model fitted to multivariate longitudinal data should prevent redundant parameter estimation in order to have greater efficiency. In this study, a multivariate marginal model is used to simultaneously investigate the factors affecting both FBS and HbA1c with longitudinal data for patients with type 2 diabetes in Northern Iran. The present research is a retrospective cohort study. Overall, 500 medical records with complete information were reviewed. The multivariate marginal model is used to determine the factors associated with FBS and HbA1c using longitudinal data. Data have been analyzed in R-3.4.0 using ‘mmm2’ package. Given that the coefficients for the interactions of rtype with the intercept, time, family history of diabetes, history of hypertension, history of smoking, insulin therapy, systolic/diastolic blood pressure and duration of disease at first visit are significantly different from zero (P < 0.05), the effect of the independent variables on the two response variables is different and different coefficients should be used for each. Therefore, the interactions of these variables with rtype are kept in the final model. The coefficients for the interactions of rtype with sex, age at first visit, history of high cholesterol, and weight are not significantly different from zero (P > 0.05), indicating that their effect on the two response variables is similar and only one coefficient should be used for each. We examined the similarity of coefficients when fitting the longitudinal multivariate model for the relationship between FBS/HbA1c and sex, age, history of high blood cholesterol, and body weight. If an independent variable has similar effects on both responses, only one coefficient should be estimated, which will increase the efficiency of the model and the reliability of the results.
Collapse
Affiliation(s)
- Samaneh Hosseinzadeh
- Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
| | - Zahra Khatirnamani
- Health Management and Social Development Research Center, Golestan University of Medical Sciences, Gorgān, Iran.
| | - Enayatollah Bakhshi
- Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
| | - Alireza Heidari
- Health Management and Social Development Research Center, Golestan University of Medical Sciences, Gorgān, Iran
| | - Arash Naghipour
- Health Management and Social Development Research Center, Golestan University of Medical Sciences, Gorgān, Iran
| |
Collapse
|
6
|
What Makes Integration of Chronic Care so Difficult? A Macro-Level Analysis of Barriers and Facilitators in Belgium. Int J Integr Care 2021; 21:8. [PMID: 34754284 PMCID: PMC8555482 DOI: 10.5334/ijic.5671] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Accepted: 09/01/2021] [Indexed: 12/30/2022] Open
Abstract
Introduction Although many countries have been implementing integrated care, the scale-up remains difficult. Macro-level system barriers play an important role. By selecting three key policies, which have implemented integrated care in Belgium over the last 10 years, we aim to go beyond the identification of their specific barriers and facilitators to obtain an overarching generic view. Methods 27 participants were purposefully selected, to include all important stakeholders involved on the macro-level in chronic care in Belgium. Semi-structured interviews were guided by a timeline of policies and an inductive thematic analysis was performed. Results Barriers and facilitators were identified on both health care and policy level. The major factors restraining the scale-up of integrated care are the fee-for-service reimbursement system, limited data sharing and the fragmentation of responsibilities between different levels of government. Remarkably, these factors strongly interact. Discussion This paper highlights the importance of homogenization of responsibilities of governments regarding integrated care and the interdependency of policy and health care system factors. A whole system change is needed instead of the current Belgian model of prolonged search for common ground between conflicting opinions. Political commitment and citizen participation will be crucial.
Collapse
|
7
|
Raat W, Smeets M, Vandewal I, Broekx L, Peters S, Janssens S, Vaes B, Aertgeerts B. Cardiologists' perceptions on multidisciplinary collaboration in heart failure care - a qualitative study. BMC Health Serv Res 2021; 21:170. [PMID: 33622318 PMCID: PMC7901167 DOI: 10.1186/s12913-021-06179-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Accepted: 02/15/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Cardiologists play a key role in multidisciplinary care by guiding heart failure (HF) management in the hospital and in the community. Regional implementation of multidisciplinary health care interventions depends on how they perceive collaboration with other health care disciplines, yet research on this topic is limited. This study aimed to explore the views and opinions of cardiologists on multidisciplinary collaboration in HF care. METHODS We conducted a qualitative study based on face-to-face semi-structured interviews with 11 Belgian cardiologists between September 2019 and February 2020. We used the Qualitative Analysis Guide of Leuven (QUAGOL) method as guidance for data analysis until data saturation was reached. RESULTS Cardiologists consider the general practitioner (GP) and HF nurse as the most important partners in HF management. Cardiologists identified four problems in current multidisciplinary collaboration: the communication of a HF diagnosis to the patient, advanced care planning, titration of HF medication by the GP and electronic data exchange and communication. Three themes emerged as ideas for improvement of HF care: 1) expansion of the role of the HF nurse, 2) implementation of a structured, patient-centered, and flexible model of disease management program and 3) integrated data approaches. CONCLUSION Cardiologists value close cooperation with GPs in HF management. They advocate an expanded future role for the HF nurse, increased eHealth, and structured disease management to optimize current HF care.
Collapse
Affiliation(s)
- Willem Raat
- Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 33, Blok J, Bus 7001, 3000, Leuven, Belgium.
| | - Miek Smeets
- Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 33, Blok J, Bus 7001, 3000, Leuven, Belgium
| | - Isolde Vandewal
- Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 33, Blok J, Bus 7001, 3000, Leuven, Belgium
| | - Lien Broekx
- Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 33, Blok J, Bus 7001, 3000, Leuven, Belgium
| | - Sanne Peters
- Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 33, Blok J, Bus 7001, 3000, Leuven, Belgium.,Ebpracticenet, Leuven, Belgium
| | - Stefan Janssens
- Department of Cardiovascular Diseases, Universitaire Ziekenhuizen Leuven, KU Leuven, Leuven, Belgium
| | - Bert Vaes
- Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 33, Blok J, Bus 7001, 3000, Leuven, Belgium
| | - Bert Aertgeerts
- Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 33, Blok J, Bus 7001, 3000, Leuven, Belgium
| |
Collapse
|
8
|
Khatirnamani Z, Bakhshi E, Naghipour A, Teymouri R, Hosseinzadeh S. Longitudinal Trend of Fasting Blood Glucose and Related Factors in Patients with Type 2 Diabetes. Int J Prev Med 2020; 11:177. [PMID: 33456733 PMCID: PMC7804876 DOI: 10.4103/ijpvm.ijpvm_195_18] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2018] [Accepted: 03/14/2019] [Indexed: 11/04/2022] Open
Abstract
BACKGROUND Control of diabetes plays an important role in improving complications and disabilities and quality of life. This study aimed to evaluate the 3-year changes in fasting blood glucose (FBG) values and its related factors in patients with type 2 diabetes. METHODS In this retrospective cohort study, 500 patients with type 2 diabetes covered by the National Diabetic Prevention and Care Plan during 2013-2016 were selected based on random cluster systematic sampling. A linear mixed model was used to study changes in FBG levels and their related factors. The data were analyzed using the R3.2.0 software. RESULTS The patients' mean age was 47.7 years. Among these patients, 58.6% were female, 19.8% had a history of smoking. High FBG was associated with high disease duration, high body mass index (BMI), low age, normal BMI at baseline, insulin therapy, smoking, and family history of diabetes. Trend of FBG in follow-up was decreasing. CONCLUSIONS Given that patients who received insulin therapy had higher mean FBG, it is recommended to examine their insulin dose and modifications should be made in terms of the patients' needs during their continuous follow-up. Weight loss during follow-up and cessation of smoking indicate a favorable prognosis of disease. More attention should be paid to younger patients in care. Patients are encouraged to start treatment and care at the same time diagnose.
Collapse
Affiliation(s)
- Zahra Khatirnamani
- Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
| | - Enayatollah Bakhshi
- Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
| | - Arash Naghipour
- Health Center Complex, Prevention and Control of Diseases Unit, Gorgan, Iran
| | - Robab Teymouri
- Pediatric Neurorehabilitation Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
| | - Samaneh Hosseinzadeh
- Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
| |
Collapse
|
9
|
Pavlov R, Topličan I, Vrcić Keglević M. Ten-Year Trends in the Morbidity of Diabetes Mellitus and Antidiabetic Drug Utilization in Croatia: A Study Based on Routinely Collected Data. INTERNATIONAL JOURNAL OF FAMILY MEDICINE 2016; 2016:9837496. [PMID: 27462470 PMCID: PMC4947653 DOI: 10.1155/2016/9837496] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/31/2015] [Revised: 05/19/2016] [Accepted: 05/24/2016] [Indexed: 06/06/2023]
Abstract
Objectives. To investigate trends of diabetes mellitus (DM) morbidity and antidiabetic drug utilization in Croatian primary health care (PHC) from 2005 to 2014. Method. Routinely collected morbidity data from all PHC units, presented in Croatian health-statistics yearbooks, were retrieved. Data on drug utilization were retrieved from the Annual Reports of the Croatian Agency for Medicinal Products and Medical Devices (ATC/DDD, antidiabetic, A10). Results. Total morbidity increased by 33.3% and DM increased by 65.6%, mostly in patients over age 65 (from 50% to 57%). Estimated DM prevalence in adults increased from 3.9% to 6.4%. Increased morbidity was followed by an even higher increase in drug utilization (120%). Metformin was first, with a constant increase (from 18% to 39%), followed by glimepiride, while glibenclamide use decreased. Total utilization of insulin increased even more, mostly for aspart (600%) and newly introduced glargine and detemir, while human insulin usage sharply decreased. Spending also increased, mostly for aspart (from 21% to 61% of total). Conclusions. Increased DM is followed by a higher increase in antidiabetic drug utilization; this trend will continue in the future. In Croatian PHC, metformin has primacy along with insulin analogues.
Collapse
Affiliation(s)
- Renata Pavlov
- Family Practice “Dr. Renata Pavlov”, Aleja lipa 2a, 10000 Zagreb, Croatia
| | - Ivančica Topličan
- Family Practice “Dr. Ivančica Topličan”, Aleja lipa 2a, 10000 Zagreb, Croatia
| | - Mladenka Vrcić Keglević
- Foundation for the Development of Family Medicine in Croatia, Cresnjevec 32, 10000 Zagreb, Croatia
| |
Collapse
|